Dr. Tim Gershon, a pediatric neurologist at Children’s Healthcare of Atlanta and director of Emory University’s Children’s Center for Neurosciences Research, says he and an international team of researchers have made a significant breakthrough in researching treatments for medulloblastoma, a common brain tumor in children.
Gershon’s team has found that a new drug, CT-179, can target cancer stem cells responsible for regrowth after treatment, which currently has a 100% mortality rate.
In preclinical trials with mice, combining CT-179 with radiation therapy helped prevent tumor recurrence.
Read this story now for free
To continue reading, sign up for our newsletter and get unlimited access to WABE.org
You can select your preferences for news and local content. We will never share your email address. Learn how your newsletter sign-up will support WABE and Public Media
